Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Charles River Laboratories International, Inc. (NYSE: CRL)
CRL Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-1.90%
Analyst Rating:
BUY
Analyst Forecast (1yr):
8.20%
CRL Stock Analysis
CRL
PE Ratio:
CRL
PEG Ratio:
CRL
Forward EPS Growth (12 month):
10.90%
CRL
PS Ratio:
2.2
CRL
PSG Ratio:
1
CRL
Forward Revenue Growth (12 month):
2.20%
CRL Articles
No data was found